Skip to content

SpineCor Treatment

SpineCor® treatment was developed in the early 1990s and utilises a Dynamic Corrective Brace (DCB), together with a completely new treatment approach requiring clinical assistant diagnostic software (SAS) to allow accurate fitting and treatment follow up.

Following 12 years of clinical research and trials, SpineCor® is now rapidly being made available to patients around the world.

The initial excellent clinical results produced by the research centre at Ste Justine Hospital and the University of Montreal, Canada, have since been replicated by more than 80 other treatment centres around the world.  SpineCor® has shown to be effective in 89% of cases (either by stablisation or improvement in (Cobb) angle of the curve.

SpineCor®’s unique treatment approach offers improvement over traditional braces, which are essentially static or allow minimal movement, due to its true totally dynamic action.  Fundamental research by independent research groups now indicates that a significant dynamic action is required on the spine (vertebral growth plates) to alter the abnormal growth progressing the deformity in scoliosis patients.

The SpineCor® treatment approach is completely different to that of traditional braces that use 3-point pressure and distraction; it is the first and only true dynamic bracing system for idiopathic scoliosis.  SpineCor®’s unique approach to treatment by global postural re-education has been shown to give progressive correction over time which, unlike any previous brace treatment, is extremely stable post brace weaning.

Clinical experience to date also shows better compliance and cosmetic results.


  • Allows patients four hours per day out of brace

  • Allows total freedom of movement

  • Offers better cosmesis under clothing, and

  • Is cooler to wear.

With all of these benefits, it is not difficult to see why compliance might be better than with bulky, rigid braces that severely restrict movement and must be worn 23 hours per day.

Although to date no specific study has been undertaken to quantify cosmetic improvement, subjectively, some striking improvements have been observed clinically.  Additionally, some very positive postural changes have been noted in cases where there has been no change in Cobb angle.


SpineCor® offers:

  • A treatment approach based on the latest understanding of the cause and progression factors of Idiopathic scoliosis.

  • A much more acceptable treatment to patients, being cooler to wear, less restrictive, more easily concealed under clothing and 4 hours of out of brace time per day.

  • No side effects.  Rigid braces cause muscle atrophy and can be harmful to normal development in a growing child.

  • Excellent treatment results, particularly when treatment is started early.

  • Excellent stability of treatment results post bracing.

  • Neuromuscular integration for maintenance of improved posture.

  • Potential to reduce incidence of surgical intervention.


SpineCor® is a highly effective for the early treatment of idiopathic scoliosis as demonstrated in the case study and also offers significant benefits to patients who present late.  The real challenge is, therefore, to increase awareness of the absolute importance of early diagnosis and, that a viable treatment for early intervention is now available.  Clearly it is easier to prevent progression of a small curve than to reverse the deformity in a large curve.  Timing is of absolute importance – the later treatment is started the lesser the possibility there is to change the curve, as the child’s growth runs out so does the possibility to make any change.


Complete or near-complete correction of curves with a Cobb angle of less than 30° is possible if the SpineCor® treatment commences before the adolescent growth spurt. 

In the case of treatment commenced during or after the adolescent growth spurt or of curves with a Cobb angle of over 30°, results range from curve stabilization to significant correction (more than 6°). Results also show that patients who wear the SpineCor® brace as prescribed are 3 times less at risk of undergoing surgical fusion (3, 40).

A study conducted in 2003 by The SpineCorporation demonstrated that the SpineCor® brace corrects or stabilizes adolescent idiopathic scoliosis in 89% of cases. In 2006, the Scoliosis Research Society (SRS) published its standardized idiopathic scoliosis research criteria, restricting study to high-risk cases only (Cobb angle 25°–40°, Risser sign 0–3). Following these modifications, new results published in 2007 put the therapeutic success* of SpineCor® at 59% (3), ), which is far superior to that of rigid braces, evaluated at between 15 and 31% (40).

Other uses for the SpineCor® brace

Old Man with the SpineCor Brace
Although the SpineCor® brace was originally developed to treat adolescent idiopathic scoliosis (AIS), subsequent clinical trials have successfully also allowed us to apply the dynamic brace to the treatment of hyperkyphosis (restructuring) and spondylolisthesis (stabilization).The SpineCor® brace can also be used to treat spinal deformities in adults (scoliosis, hyperkyphosis, spondylolisthesis). See SPINECOR – FAQ ADULTS. It can improve postural alignment, prevent curve progression due to ageing, as well as significantly reduce pain. It has proven to be an unparalleled solution for treating these medical conditions.Because the corrective bands can be arranged in countless different ways, the SpineCor® dynamic brace has extraordinary potential for development. Future research will no doubt uncover numerous other clinical applications